NCI Division of Cancer Biology shared on LinkedIn:
“An NIH-funded study showed that erythropoietin (a hormone that stimulates the production of red blood cells) secreted by tumor cells promotes an immunosuppressive tumor microenvironment in liver cancer models. It also found that blocking erythropoietin signaling enhances immune responses to tumors.”
Title: Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity
Authors: David Kung-Chun Chiu, Xiangyue Zhang, Bowie Yik-Ling Cheng, Qiang Liu, Kazukuni Hayashi, Bo Yu, Ryan Lee, Catherine Zhang, Xiuli An, Jayakumar Rajadas, Nathan E. Reticker-Flynn, Erinn B. Rankin, Edgar G. Engleman
Read an insightful article about Liver Cancer.
